Skip to main content
Figure 9 | BMC Cancer

Figure 9

From: Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells

Figure 9

Dose response of TRAIL with single mitoxantrone and mithramycin concentrations in PC3-TR cells. Mitoxantrone treatments are shown as "dark grey diamonds" and mithramycin treatments are shown as "light grey squares". Asterisks (*) and (**) indicate p-values < 0.05 and < 0.01, respectively. Data are presented on a logarithmic scale and the lines connecting data points are for visualization only.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us